Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2005 | 04-2004 | 04-2003 | 04-2002 | 04-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -106 | -215 | -146 | -147 | -677 |
| Depreciation Amortization | 48 | 48 | 48 | 48 | 56 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 208 |
| Accounts receivable | 23 | -23 | N/A | N/A | 113 |
| Accounts payable and accrued liabilities | -23 | 28 | -23 | -38 | 78 |
| Other Working Capital | 163 | 99 | -151 | 16 | 266 |
| Other Operating Activity | -140 | -5 | 23 | 88 | 100 |
| Operating Cash Flow | $-36 | $-68 | $-248 | $-33 | $145 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -3 | -9 | -14 | -34 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -242 |
| Investing Cash Flow | $N/A | $-3 | $-9 | $-14 | $-276 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -4 | -2 | -10 | -8 |
| Other Financing Activity | 0 | 0 | 5 | 55 | 0 |
| Financing Cash Flow | $N/A | $-4 | $3 | $45 | $-8 |
| Beginning Cash Position | 120 | 195 | 449 | 452 | 591 |
| End Cash Position | 85 | 120 | 195 | 449 | 452 |
| Net Cash Flow | $-36 | $-75 | $-254 | $-2 | $-140 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36 | -68 | -248 | -33 | 145 |
| Capital Expenditure | N/A | -3 | -9 | -14 | -34 |
| Free Cash Flow | -36 | -71 | -257 | -47 | 111 |